Evidence map›Paper›PMID 30692974›Full record

ArticleFrontiers in microbiology2018

Intricate Crosstalk Between Lipopolysaccharide, Phospholipid and Fatty Acid Metabolism in

Nikolas Thomanek, Jan Arends, Claudia Lindemann, Katalin Barkovits, Helmut E Meyer, Katrin Marcus, Franz Narberhaus

Open access · goldAbstract read
In one paragraph

Article in Frontiers in microbiology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 37 papers.

0numbers the graph read from it
0cells of the map it votes in
37citing papers in PubMed
5.4field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

37 citing papers in PubMed, 49 citations in OpenAlex.

  1. LPS in gram-negative bacterial growth and physiology: outside but fully integrated.Microbiology and molecular biology reviews : MMBR · 2026
    Review
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Review
  8. Review
  9. Review
  10. Signaling through theJournal of bacteriology · 2024
    Article
  11. Fingolimod synergizes and reversesFrontiers in microbiology · 2024
    Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Adaptive Responses ofAntimicrobial agents and chemotherapy · 2022
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Nikolas ThomanekMedical Proteome Center, Ruhr University Bochum, Bochum, Germany.
Jan ArendsMicrobial Biology, Ruhr University Bochum, Bochum, Germany.
Claudia LindemannMedical Proteome Center, Ruhr University Bochum, Bochum, Germany.
Katalin BarkovitsMedical Proteome Center, Ruhr University Bochum, Bochum, Germany.
Helmut E MeyerMedical Proteome Center, Ruhr University Bochum, Bochum, Germany.
Katrin MarcusMedical Proteome Center, Ruhr University Bochum, Bochum, Germany.
Franz NarberhausMicrobial Biology, Ruhr University Bochum, Bochum, Germany.
Ruhr University Bochum · DELeibniz Institute for Analytical Sciences - ISAS · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Lipopolysaccharides (LPS) in the outer membrane of Gram-negative bacteria provide the first line of defense against antibiotics and other harmful compounds. LPS biosynthesis critically depends on LpxC catalyzing the first committed enzyme in this process. In

Indexed as

Escherichia colilipopolysaccharidephospholipidppGppproteolysisquantitative proteomicssuper-SILAC

Identifiers

PMID30692974
PMCPMC6339880
OpenAlexW2910920005

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.